Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Non Operating Income (2016)

China Pharma Holdings (CPHI) has disclosed Other Non Operating Income for 5 consecutive years, with -$3324.0 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Other Non Operating Income rose 78.06% year-over-year to -$3324.0, compared with a TTM value of $1.6 million through Dec 2016, down 4.15%, and an annual FY2016 reading of $343023.0, down 79.09% over the prior year.
  • Other Non Operating Income was -$3324.0 for Q4 2016 at China Pharma Holdings, down from -$2325.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.7 million in Q3 2015 and bottomed at -$15152.0 in Q4 2015.
  • Average Other Non Operating Income over 3 years is $339993.6, with a median of -$2325.0 recorded in 2016.
  • The sharpest move saw Other Non Operating Income surged 2443.84% in 2015, then plummeted 100.14% in 2016.
  • Year by year, Other Non Operating Income stood at $65086.0 in 2014, then tumbled by 123.28% to -$15152.0 in 2015, then skyrocketed by 78.06% to -$3324.0 in 2016.
  • Business Quant data shows Other Non Operating Income for CPHI at -$3324.0 in Q4 2016, -$2325.0 in Q3 2016, and -$15152.0 in Q4 2015.